1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsClorox Company Foundation Grants is sponsored by Clorox Company Foundation. Provides grants primarily in Oakland, California, focusing on health security and community wellness.
Get alerted about grants like this
Save a search for “Clorox Company Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grant Applications | The Clorox Company The Clorox Company Foundation has an invitation-only application process and does not accept unsolicited proposals. Invitations will be sent to organizations that we have identified that align with our company values and funding priorities.
If your organization did not receive an invitation and you would like to be considered: For organizations that have not received funding within the last five years: If your organization has not received support from Clorox within the past five years, you meet current eligibility requirements and you would like to inquire about an invitation, please email cloroxfndt@eastbaycf. org , no concept paper required at the time of inquiry.
Organizations that have never received a grant from our foundation or it has been more than five years: To initiate the process for funding consideration if your organization has never received a grant from Clorox or it has been more than five years since receiving support, please submit a concept paper to cloroxfndt@eastbaycf. org .
Your concept paper should include the following information: Brief program overview, including how long your organization has been offering this program Concept papers should not exceed two pages. After a concept paper has been received, it is reviewed by a committee of the foundation who will conduct a thorough analysis.
Within one month of your email submission, you will receive an email from us with follow-up questions and/or the status of your concept paper. If we decide to move forward, the next phase typically includes a conference call and a site visit for first-time grantees. Final decisions are made during a biannual review.
Questions about invitations or concept papers, please contact: Email: cloroxfndt@eastbaycf. org Applicants must currently be in good standing with the IRS and in receipt of an IRS ruling confirming their classification as a 501(c)(3) tax-exempt, nonprofit agency or be sponsored by a qualified fiscal agent. In addition, the proposal must meet the foundation’s geographic scope and address one of the focus areas listed above.
The foundation uses the following criteria in selecting agencies for funding: Outcomes related to measurable performance (i.e., improved grades, test scores, graduation rates, increased audiences in underserved communities) Strategies that will achieve the stated outcomes Sound fiscal and management practices Involvement of board of directors Demonstrated collaborative relationships Nondiscrimination policies and practices In general, the foundation does not fund the following: Individual school projects Programs that support individual schools Fundraising events, benefits or raffles Athletic programs or league sponsorships Field trips, tours and travel expenses Advertising or promotional sponsorships Conferences, conventions, meetings, etc. Media productions (TV, radio or film projects) Projects of a national scope Direct assistance to individuals or individual sponsorships Religious-based activities for the purpose of furthering religious doctrine Political parties, organizations, candidates or activities Exclusive membership organizations and associations or membership dues Organizations that discriminate based on age, ethnicity, ancestry, gender identity, national origin, disability, race, size, religion, sexual orientation, socioeconomic background or any other status prohibited by applicable law Nonprofits on the Southern Poverty Law Center list Organizations that represent a conflict of interest with The Clorox Company’s business interests or its reputation or its relationship with others For more information, visit our FAQs .
Based on current listing details, eligibility includes: Nonprofit organizations in Oakland, CA, and surrounding areas. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.